Hims & Hers (HIMS) is down -21.0%, or -$10.80 to $40.51.
Elevate Your Investing Strategy:
- Take advantage of TipRanks Premium at 50% off! Unlock powerful investing tools, advanced data, and expert analyst insights to help you invest with confidence.
Published first on TheFly – the ultimate source for real-time, market-moving breaking financial news. Try Now>>
Read More on HIMS:
- Hims & Hers ‘beat and raise story is likely over’ in near-term, says BofA
- Hims & Hers debates ‘unresolved’ after earnings, says Morgan Stanley
- Hims & Hers price target raised to $61 from $31 at Needham
- Hims & Hers Health: Strong Performance and Strategic Investments Signal a Compelling Buy Opportunity
- Hims & Hers price target raised to $35 from $24 at Piper Sandler